Quantitative In-Vitro Diagnostic NMR Spectroscopy for Lipoprotein and Metabolite Measurements in Plasma and Serum: Recommendations for Analytical Artifact Minimization with Special Reference to COVID-19/SARS-CoV-2 Samples.

Artifacts Blood Chemical Analysis / standards Blood Specimen Collection / instrumentation COVID-19 Coronavirus Infections Hot Temperature Humans Lipoproteins / blood Magnetic Resonance Spectroscopy / methods Pandemics Pneumonia, Viral Reproducibility of Results
SARS-CoV-2 freeze−thaw information stability COVID-19 lipoproteins metabolic profiling quantitative NMR spectroscopy sample heat treatment sample preparation sample storage

Journal

Journal of proteome research
ISSN: 1535-3907
Titre abrégé: J Proteome Res
Pays: United States
ID NLM: 101128775

Informations de publication

Date de publication:
06 11 2020
Historique:
pubmed: 28 8 2020
medline: 1 12 2020
entrez: 28 8 2020
Statut: ppublish

Résumé

Quantitative nuclear magnetic resonance (NMR) spectroscopy of blood plasma is widely used to investigate perturbed metabolic processes in human diseases. The reliability of biochemical data derived from these measurements is dependent on the quality of the sample collection and exact preparation and analysis protocols. Here, we describe systematically, the impact of variations in sample collection and preparation on information recovery from quantitative proton (

Identifiants

DOI: 10.1021/acs.jproteome.0c00537 PMID: 32852212
pubmed: 32852212
doi: 10.1021/acs.jproteome.0c00537
doi:

Substances chimiques

Lipoproteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4428-4441

Auteurs

Ruey Leng Loo (RL)

Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Murdoch, Perth, WA 6150, Australia.
ORCID: 0000-0001-5307-5709

Samantha Lodge (S)

Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Murdoch, Perth, WA 6150, Australia.

Torben Kimhofer (T)

Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Murdoch, Perth, WA 6150, Australia.
ORCID: 0000-0001-7158-9930

Sze-How Bong (SH)

Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.

Sofina Begum (S)

Section for Nutrition Research, Imperial College London, Sir Alexander Fleming Building, South Kensington, London SW72AZ, U.K.

Luke Whiley (L)

Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Murdoch, Perth, WA 6150, Australia.
Perron Institute for Neurological and Translational Science, Nedlands, WA 6009, Australia.

Nicola Gray (N)

Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Murdoch, Perth, WA 6150, Australia.
ORCID: 0000-0002-0094-5245

John C Lindon (JC)

Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Murdoch, Perth, WA 6150, Australia.
Department of Metabolism, Nutrition and Reproduction, Imperial College London, Sir Alexander Fleming Building, London SW72AZ, U.K.
ORCID: 0000-0002-0916-6360

Philipp Nitschke (P)

Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Murdoch, Perth, WA 6150, Australia.

Nathan G Lawler (NG)

Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Murdoch, Perth, WA 6150, Australia.

Hartmut Schäfer (H)

Biospin GmbH, Silberstreifen, 76287 Rheinstetten, Germany.

Manfred Spraul (M)

Biospin GmbH, Silberstreifen, 76287 Rheinstetten, Germany.

Toby Richards (T)

Division of Surgery, Medical School, Faculty of Health and Medical Sciences, University of Western Australia, Harry Perkins Building, Robert Warren Drive, Murdoch, Perth, WA 6150, Australia.
Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Harry Perkins Building, Murdoch, Perth, WA 6150, Australia.

Jeremy K Nicholson (JK)

Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Murdoch, Perth, WA 6150, Australia.
Division of Surgery, Medical School, Faculty of Health and Medical Sciences, University of Western Australia, Harry Perkins Building, Robert Warren Drive, Murdoch, Perth, WA 6150, Australia.
Institute of Global Health Innovation, Imperial College London, Level 1, Faculty Building, South Kensington Campus, London SW72NA, U.K.

Elaine Holmes (E)

Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, WA 6150, Australia.
Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Murdoch, Perth, WA 6150, Australia.
Section for Nutrition Research, Imperial College London, Sir Alexander Fleming Building, South Kensington, London SW72AZ, U.K.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Techniques d'investigation › Artéfacts › Quantitative In-Vitro Diagnostic NMR...
questionsmedicales.fr › Techniques d'investigation › Techniques de laboratoire clinique › Tests de chimie clinique › Analyse chimique du sang › Quantitative In-Vitro Diagnostic NMR...
questionsmedicales.fr › Techniques d'investigation › Techniques de laboratoire clinique › Manipulation d'échantillons › Prélèvement d'échantillon sanguin › Quantitative In-Vitro Diagnostic NMR...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Quantitative In-Vitro Diagnostic NMR...
questionsmedicales.fr › Infection › Maladies virales › Infections à virus à ARN › Infections à Nidovirales › Infections à Coronaviridae › Infections à coronavirus › Quantitative In-Vitro Diagnostic NMR...
questionsmedicales.fr › Environnement et santé publique › Environnement › Concepts météorologiques › Atmosphère › Temps (météorologie) › Température › Température élevée › Quantitative In-Vitro Diagnostic NMR...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Quantitative In-Vitro Diagnostic NMR...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Lipoprotéines › Quantitative In-Vitro Diagnostic NMR...
questionsmedicales.fr › Techniques d'investigation › Techniques de chimie analytique › Analyse spectrale › Spectroscopie par résonance magnétique › Quantitative In-Vitro Diagnostic NMR...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Épidémies de maladies › Épidémies › Pandémies › Quantitative In-Vitro Diagnostic NMR...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › Quantitative In-Vitro Diagnostic NMR...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Méthodologie en recherche épidémiologique › Reproductibilité des résultats › Quantitative In-Vitro Diagnostic NMR...